Advertisement

Latest News

FDA Approves Crinecerfont for Congenital Adrenal Hyperplasia

16 hours ago

Crinecerfont is indicated to be used with glucocorticoids to control androgen levels in adults and pediatric patients with classic congenital adrenal hyperplasia.

Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D

18 hours ago

Jennifer B. Green, MD highlights the successful implementation of evidence-based therapies for high-risk patients with type 2 diabetes.

Upadacitinib Sustained Efficacy, Safety Among Patients with Atopic Dermatitis Over 188 Weeks

19 hours ago

This interim analysis highlights positive findings from the Measure Up 1 and 2 studies regarding upadacitinib for patients with atopic dermatitis.

Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D

19 hours ago

Ralph A. DeFronzo, MD discusses the Noxious Nine and the impact of hypercortisolism on difficult-to-control type 2 diabetes.

Study Finds No Link Between Therapist CBT Skill and Patient Outcomes

20 hours ago

A study finds that therapists deliver high-quality CBT in routine psychiatric care but found no evidence that therapist adherence and competence correlate to patient outcomes.

Advertisement
Advertisement